F. Buttgereit, C. Dejaco, and E. Matteson, Polymyalgia Rheumatica and Giant Cell Arteritis, JAMA, vol.315, issue.22, pp.2442-58, 2016.
DOI : 10.1001/jama.2016.5444

J. Jennette, R. Falk, and P. Bacon, 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, Arthritis and rheumatism, vol.653, pp.1-11, 2013.

T. Kermani, J. Schmidt, and C. Crowson, Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Seminars in arthritis and rheumatism 2012 The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis and rheumatism, vol.41335, pp.866-711122, 1990.

D. Lariviere, K. Sacre, and I. Klein, Extra- and Intracranial Cerebral Vasculitis in Giant Cell Arteritis, Medicine, vol.93, issue.28, pp.265-271, 2014.
DOI : 10.1097/MD.0000000000000265

N. Amiri, D. Vera, M. Choi, and H. , Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis, Rheumatology Arthritis and rheumatism Medicine, vol.55418889, pp.33-4026, 1998.

A. Hussami, C. Casulli, and C. Fayard, Vertebrobasilar stroke secondary to giant-cell arteritis without biological inflammatory syndrome, Revue Neurologique, vol.172, issue.3, pp.250-252, 2016.
DOI : 10.1016/j.neurol.2015.12.006

J. Narvaez, B. Bernad, and C. Gomez-vaquero, Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis, Clinical and experimental rheumatology, vol.2611, pp.57-62, 2008.

G. Nesher, Y. Berkun, and M. Mates, Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis Predictors of cerebrovascular accidents in giant cell arteritis in a defined population Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature, Arthritis and rheumatism Clinical and experimental rheumatology Medicine, vol.501222138714, pp.1332-1339, 2004.

G. Tomasson, C. Peloquin, and A. Mohammad, Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis, Annals of Internal Medicine, vol.160, issue.2, pp.73-80, 2014.
DOI : 10.7326/M12-3046

P. Ungprasert, K. Wijarnpreecha, and M. Koster, Cerebrovascular accident in patients with giant cell arteritis: A systematic review and meta-analysis of cohort studies. Seminars in arthritis and rheumatism 2016

N. Horie, Y. Tateishi, and M. Morikawa, Acute stroke with major intracranial vessel occlusion: Characteristics of cardioembolism and atherosclerosis-related in situ stenosis/occlusion, Journal of Clinical Neuroscience, vol.32, pp.24-33, 2016.
DOI : 10.1016/j.jocn.2015.12.043

M. Gonzalez-gay, A. Pineiro, and A. Gomez-gigirey, Influence of Traditional Risk Factors of Atherosclerosis in the Development of Severe Ischemic Complications in Giant Cell Arteritis, Medicine, vol.83, issue.6, pp.342-349, 2004.
DOI : 10.1097/01.md.0000145369.25558.b5

J. Narvaez, B. Bernad, and J. Nolla, Statin Therapy Does not Seem to Benefit Giant Cell Arteritis, Seminars in Arthritis and Rheumatism, vol.36, issue.5, pp.322-329, 2007.
DOI : 10.1016/j.semarthrit.2006.10.001